Monday, 30 August 2010

Neptune Technologies Returns To The Fold

Neptune Technologies & Bioressources
Basic Shares: 40.2 million
Fully diluted: 43.1 million

Montreal based Neptune and The Howard Group have rejoined hands in an effort aimed at the capital markets and investor relations activities going forward.

NTB and HG had a successful two-year partnership from December 2005 to the end of 2007 that was a period of great expectation and market valuation for the producer of krill oil with its patented and proprietary processes.

This is somewhat a case of deja vu as the stock price was in the range of a $1 the first time around and currently sits 25% above that number after reaching a peak in excess of $8 in 2007.

The difference is the positive strides the Company has made in terms of revenue and production increases as well as what its accomplished in relation to the goal of ultimately reaching a deal with a pharma company for "natural" drug applications.

We have written a detailed and extensive introductory commentary on Neptune that looks at what it has done over the last several years, where it is going in key fronts and discusses the important question of market expectation and valuation.

To read the commentary click here.